Pulmonology clinical trials recruiting in Pennsylvania

88 recruiting pulmonology trials match in Pennsylvania. Showing 20.

• Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  N/A · University of Pittsburgh · Pittsburgh, Pennsylvania

• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRecruiting

  Phase 2 · AstraZeneca · Camp Hill, Pennsylvania

• Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)Recruiting

  N/A · Boston Children's Hospital · Pittsburgh, Pennsylvania

• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningRecruiting

  N/A · Freenome Holdings Inc. · DuBois, Pennsylvania

• Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyRecruiting

  Phase 3 · GlaxoSmithKline · DuBois, Pennsylvania

• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeRecruiting

  N/A · Temple University · Bethlehem, Pennsylvania

• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  Phase 2 · Cumberland Pharmaceuticals · Philadelphia, Pennsylvania

• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruiting

  Phase 2 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruiting

  Phase 2 · InSilico Medicine Hong Kong Limited · Philadelphia, Pennsylvania

• STRIVE Post-Market Registry StudyRecruiting

  N/A · Olympus Corporation of the Americas · Hershey, Pennsylvania

• Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Recruiting

  Phase 3 · AstraZeneca · Cullman, Alabama

• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDRecruiting

  Phase 2 · Johns Hopkins University · Baltimore, Maryland

• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Recruiting

  Phase 2 · Deciphera Pharmaceuticals, LLC · Pittsburgh, Pennsylvania

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisRecruiting

  Phase 2 · UCB Biopharma SRL · DuBois, Pennsylvania

• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting

  N/A · Duke University · Palo Alto, California

• Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIVRecruiting

  N/A · University of Pittsburgh · Pittsburgh, Pennsylvania

• Phase 2 Study to Assess the Safety and Efficacy of ANG003Recruiting

  Phase 2 · Anagram Therapeutics, Inc. · Hershey, Pennsylvania

• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose IntoleranceRecruiting

  Phase 2 · University of Pennsylvania · Philadelphia, Pennsylvania

• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentRecruiting

  Phase 3 · AstraZeneca · DuBois, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.